Galmed Pharmaceuticals Ltd (FRA:GPH) Stock News, Headlines & Updates
Galmed Pharmaceuticals Ltd Stock News from GuruFocus
- 1
May 27, 2025
Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH
PRNewswire • 8:00am
Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH | GLMD Stock News
GuruFocus News • 7:19am
May 22, 2025
Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
PRNewswire • 8:00am
Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | GLMD Stock News
GuruFocus News • 7:17am
May 13, 2025
Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models
PRNewswire • 8:00am
Galmed (GLMD) Announces Promising Pre-Clinical Results for Aramchol in Treating PSC | GLMD Stock News
GuruFocus News • 7:22am
Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models | GLMD Stock News
GuruFocus News • 7:17am
May 06, 2025
GLMD Advances Cancer Treatment with Promising Aramchol Results | GLMD Stock News
GuruFocus News • 7:03am
GLMD: Galmed's Aramchol Boosts Cancer Drug Efficacy in Early Studies | GLMD Stock News
GuruFocus News • 7:01am
Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models
PRNewswire • 7:00am
Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models | GLMD Stock News
GuruFocus News • 6:47am
Apr 28, 2025
Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation
PRNewswire • 8:00am
Galmed (GLMD) Pharmaceuticals Signs Licensing Agreement for Drug Delivery System | GLMD Stock News
GuruFocus News • 7:20am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news